DDR Alterations as a Surrogate Marker for TMB in SCLC - Use it or Lose it?

Affiliations

• ¹ Cancer Immuno-Biology Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Australia; Department of Medical Oncology, Austin Health, Heidelberg, Australia; School of Cancer Medicine, La Trobe University, Heidelberg, Australia. Electronic address: surein.arulananda@onjcri.org.au.
• ² Cancer Immuno-Biology Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Australia; Department of Medical Oncology, Austin Health, Heidelberg, Australia.
• ³ Cancer Immuno-Biology Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Australia; Department of Medical Oncology, Austin Health, Heidelberg, Australia; School of Cancer Medicine, La Trobe University, Heidelberg, Australia.